Theratechnologies Income Statement

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May '25 May 31, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020
Revenue	84.38	85.87	81.76	80.06	69.82	66.05
Revenue Growth (YoY)	2.19%	5.02%	2.13%	14.66%	5.71%	4.49%
Cost of Revenue	18.8	20.45	19.64	23.84	18.38	22.02
Gross Profit	65.58	65.42	62.13	56.22	51.45	44.03
Selling, General & Admin	42.94	38.83	39.29	47.54	40.35	39.09
Research & Development	14.08	16.97	28.99	36.94	28.27	18.02
Operating Expenses	58.46	57.24	70.79	96.13	76.68	61.99
Operating Income	7.12	8.17	-8.66	-39.91	-25.24	-17.96
Interest Expense	-7.31	-10.42	-11.32	-6.5	-5.66	-5.36
Interest & Investment Income	0.79	1.49	0.77	0.32	0.2	0.72
Currency Exchange Gain (Loss)	0.29	0.46	1.1	-1.03	-0.93	-
Other Non Operating Income (Expenses)	-0.33	-0.11	-0.04	-0.04	-0.03	-0.05
EBT Excluding Unusual Items	0.57	-0.4	-18.15	-47.15	-31.66	-22.65
Merger & Restructuring Charges	-	-	-1.96	-	-	-
Gain (Loss) on Sale of Investments	-1.52	-	-	-	-	-
Other Unusual Items	-5.87	-5.9	-3.42	0.36	-	-
Pretax Income	-6.83	-6.3	-23.54	-46.79	-31.66	-22.65
Income Tax Expense	2.33	2.01	0.42	0.44	0.06	0.02
Net Income	-9.16	-8.31	-23.96	-47.24	-31.73	-22.67
Net Income to Common	-9.16	-8.31	-23.96	-47.24	-31.73	-22.67
Shares Outstanding (Basic)	49	49	26	24	23	19
Shares Outstanding (Diluted)	49	49	26	24	23	19
Shares Change (YoY)	26.85%	87.46%	10.58%	3.14%	19.95%	0.08%
EPS (Basic)	-0.19	-0.17	-0.91	-1.98	-1.37	-1.18
EPS (Diluted)	-0.19	-0.17	-0.91	-1.98	-1.37	-1.18
Free Cash Flow	7.03	2.38	-6	-15.68	-17.63	-13.59
Free Cash Flow Per Share	0.14	0.05	-0.23	-0.66	-0.76	-0.71
Gross Margin	77.72%	76.19%	75.99%	70.22%	73.68%	66.66%
Operating Margin	8.44%	9.52%	-10.60%	-49.85%	-36.14%	-27.19%
Profit Margin	-10.85%	-9.67%	-29.30%	-59.00%	-45.44%	-34.32%
Free Cash Flow Margin	8.33%	2.77%	-7.33%	-19.58%	-25.25%	-20.57%
EBITDA	8.75	10.6	-5.7	-27.87	-16.94	-9.88
EBITDA Margin	10.36%	12.34%	-6.97%	-34.81%	-24.26%	-14.95%
D&A For EBITDA	1.62	2.42	2.96	12.04	8.3	8.08
EBIT	7.12	8.17	-8.66	-39.91	-25.24	-17.96
EBIT Margin	8.44%	9.52%	-10.60%	-49.85%	-36.14%	-27.19%

Updated Jul 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q